Marc Hertz - GRI Bio President Director
GRI Etf | USD 0.74 0.05 7.25% |
Age | 54 |
Address | 2223 Avenida de la Playa, LA Jolla, CA, United States, 92037 |
Phone | 619 400 1170 |
Web | https://www.gribio.com |
GRI Bio Management Efficiency
The company has Return on Asset of (0.8253) % which means that on every $100 spent on assets, it lost $0.8253. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.8906) %, meaning that it generated no profit with money invested by stockholders. GRI Bio's management efficiency ratios could be used to measure how well GRI Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
Found 7 records | One Year Return | ||
Anish Suri | Cue Biopharma | 50 | |
Wubin MBA | Connect Biopharma Holdings | 59 | |
David JD | Connect Biopharma Holdings | 50 | |
David Szekeres | Connect Biopharma Holdings | 50 | |
Edna MD | Prelude Therapeutics | 51 | |
Pratik Shah | Design Therapeutics | 54 | |
Rodolfo Chaparro | Cue Biopharma | 51 |
Management Performance
Return On Equity | -1.89 | ||||
Return On Asset | -0.83 |
GRI Bio Money Managers
Cristina White, Interim Officer | ||
Albert Agro, CoFounder Officer | ||
Marc Hertz, President Director | ||
Vipin Chaturvedi, CoFounder Officer | ||
Leanne Kelly, CFO Secretary |
GRI Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is GRI Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.89 | ||||
Return On Asset | -0.83 | ||||
Current Valuation | 1.99 M | ||||
Shares Outstanding | 8.93 M | ||||
Shares Owned By Insiders | 0.35 % | ||||
Shares Owned By Institutions | 4.70 % | ||||
Number Of Shares Shorted | 924.63 K | ||||
Price To Earning | 23.35 X | ||||
Price To Book | 1.80 X | ||||
Revenue | 21.77 M |
Currently Active Assets on Macroaxis
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.